Chromocell Therapeutics (CHRO) Stock Chart & Stock Price History

$1.76
-0.03 (-1.68%)
(As of 10:47 AM ET)

Chromocell Therapeutics Stock Price Performance

5 Day
Performance
+10.00%
1 Month
Performance
-26.36%
Receive CHRO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chromocell Therapeutics and its competitors with MarketBeat's FREE daily newsletter

CHRO Stock Chart for Wednesday, May, 1, 2024

Chromocell Therapeutics Share Price History

DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
04/30/2024$1.62$1.79
+10.49%
$1.79$1.6214,916 shs$10.53 million
04/29/2024$1.60$1.62
+1.25%
$1.73$1.565,215 shs$9.53 million
04/26/2024$1.50$1.60
+6.67%
$1.78$1.4726,702 shs$6.21 million
04/25/2024$1.57$1.50
-4.46%
$1.66$1.499,681 shs$5.82 million
04/24/2024$1.56$1.57
+0.64%
$1.63$1.5010,300 shs$6.09 million
04/23/2024$1.40$1.56
+11.43%
$1.80$1.3116,344 shs$6.05 million
04/22/2024$1.54$1.40
-9.09%
$1.64$1.4026,192 shs$5.43 million
04/19/2024$1.23$1.54
+25.71%
$1.75$1.30119,182 shs$5.98 million
04/18/2024$1.99$1.23
-38.44%
$1.87$1.2126,306 shs$4.75 million
04/17/2024$1.82$1.99
+9.34%
$2.04$1.8311,312 shs$7.72 million
04/16/2024$1.95$1.82
-6.67%
$1.95$1.6123,087 shs$7.06 million
04/15/2024$2.00$1.95
-2.44%
$2.25$1.8937,059 shs$7.57 million
04/12/2024$1.83$2.00
+9.19%
$2.00$1.816,414 shs$7.76 million
04/11/2024$1.86$1.83
-1.32%
$1.94$1.816,007 shs$7.10 million
04/10/2024$1.97$1.86
-5.84%
$1.91$1.838,755 shs$7.20 million
04/09/2024$2.15$1.97
-8.37%
$2.19$1.9028,111 shs$7.64 million
04/08/2024$2.29$2.15
-6.11%
$2.33$2.0319,003 shs$8.33 million
04/05/2024$2.34$2.29
-2.14%
$2.58$2.2921,798 shs$8.89 million
04/04/2024$2.59$2.34
-9.65%
$2.45$2.3312,249 shs$9.07 million
04/03/2024$2.40$2.59
+7.92%
$2.59$2.3314,139 shs$10.05 million
04/02/2024$2.39$2.40
+0.42%
$2.50$2.3329,246 shs$9.31 million
04/01/2024$2.62$2.39
-8.78%
$2.66$2.3927,018 shs$9.27 million
03/29/2024$2.62$2.62$2.74$2.5531,842 shs$10.16 million
03/28/2024$2.71$2.62
-3.32%
$2.74$2.5531,847 shs$10.17 million
03/27/2024$2.44$2.71
+11.07%
$2.75$2.40163,598 shs$10.52 million
03/26/2024$2.50$2.44
-2.40%
$2.62$2.3721,645 shs$9.47 million
03/25/2024$2.46$2.50
+1.63%
$2.70$2.3235,956 shs$9.70 million
03/22/2024$2.78$2.46
-11.51%
$2.82$2.4665,557 shs$9.55 million
03/21/2024$2.87$2.78
-3.14%
$2.99$2.6536,989 shs$10.79 million
03/20/2024$3.04$2.87
-5.59%
$3.05$2.7517,324 shs$11.14 million
03/19/2024$3.13$3.04
-2.88%
$3.14$2.6333,939 shs$11.78 million
03/18/2024$3.31$3.13
-5.44%
$3.33$3.0316,193 shs$12.14 million
03/15/2024$3.38$3.31
-2.07%
$3.50$3.1624,690 shs$12.84 million
03/14/2024$3.58$3.38
-5.59%
$3.65$3.3811,594 shs$13.10 million
03/13/2024$3.45$3.58
+3.77%
$3.68$3.5016,607 shs$13.89 million
03/12/2024$3.32$3.45
+3.92%
$3.65$3.3123,656 shs$13.39 million
03/11/2024$3.54$3.32
-6.21%
$3.63$3.2923,375 shs$12.88 million
03/08/2024$3.62$3.54
-2.21%
$3.61$3.2515,138 shs$13.74 million
03/07/2024$3.38$3.62
+7.10%
$3.65$3.4013,835 shs$14.05 million
03/06/2024$3.27$3.38
+3.36%
$3.55$3.2812,710 shs$13.11 million
Trump’s last act as President (Ad)

You’ve probably never heard of Executive Order #13972. Signed by President Trump just days before leaving office, it greenlit what could be the most revolutionary technology of the decade… yet it has nothing to do with AI, blockchain, or mRNA vaccines.

For the full story, click here.
03/05/2024$3.27$3.27
0.00%
$3.55$3.2619,120 shs$12.68 million
03/04/2024$3.65$3.27
-10.41%
$3.82$3.1634,629 shs$12.69 million
03/01/2024$3.77$3.65
-3.18%
$3.84$3.6513,308 shs$14.16 million
02/29/2024$3.75$3.77
+0.53%
$3.94$3.768,377 shs$14.63 million
02/28/2024$4.00$3.75
-6.25%
$4.26$3.7516,868 shs$14.55 million
02/27/2024$4.20$4.00
-4.76%
$4.36$4.0030,117 shs$15.52 million
02/26/2024$4.33$4.20
-3.00%
$4.74$4.0272,388 shs$16.30 million
02/23/2024$4.80$4.33
-9.79%
$4.74$4.335,737 shs$0.00
02/22/2024$4.78$4.80
+0.42%
$4.80$4.504,916 shs$0.00
02/21/2024$4.80$4.78
-0.42%
$4.84$4.3410,524 shs$0.00
02/20/2024$4.80$4.80$4.80$3.7025,437 shs$0.00
02/19/2024N/A$4.80$6.00$4.54357,100 shs$0.00

This page (NYSE:CHRO) was last updated on 5/1/2024 by MarketBeat.com Staff

From Our Partners